FCGR1A and bipolar disorder: We previously reported increases in CD163 and CD64 mRNAs in schizophrenia compared to controls and bipolar disorder [50]; however, expression of no other peripheral immune cell markers or ICAM1 differed across diagnosis (Supplementary Fig. S3).